targeting apoptosis - developing drugs to inhibit bcl-2 and mcl-1
Published 7 years ago • 862 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
2:30
novel bcl-2 & bcl-2/bclxl inhibitors emerging for the treatment of hematological malignancies
-
1:27
advances in btk and bcl2 inhibitors for cll
-
8:31
targeting bcl-2 in mds
-
1:14
the use of the process of apoptosis for cancer treatments
-
0:49
the future of inhibiting bcl2 for the treatment of t-all
-
1:47
targeting apoptosis in multiple myeloma
-
5:30
targeting ror1 and a two-drug approach to cure cll
-
6:19
harnessing apoptosis in aml
-
2:02
targeting the survival cascade of b-cells in lymphoid malignancies
-
1:14
novel inducers of apoptosis in double-refractory cll cells
-
2:16
bcl-2 targeting in aml: updates
-
2:41
the potential of targeting cd123 in myeloid malignancies
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
3:15
using targeted therapies to optimize transplant outcomes in aml
-
1:25
therapeutic targeting of splicing factor mutations in myeloid malignancies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:40
new therapeutic approaches targeting xpo1-overexpression in tp53-mutated myeloid malignancies
-
1:13
dual-targeted regimens for the treatment of cll: anti-cd20 antibodies, btki, and bcl2i